药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Phenazopyridine
Taxifolin
The therapeutic efficacy of Selexipag can be decreased when used in combination with Taxifolin.
Phenazopyridine
Etoricoxib
The therapeutic efficacy of Selexipag can be decreased when used in combination with Etoricoxib.
Phenazopyridine
Tiaprofenic acid
The therapeutic efficacy of Selexipag can be decreased when used in combination with Tiaprofenic acid.
Phenazopyridine
Mometasone furoate
The metabolism of Selexipag can be decreased when combined with Mometasone furoate.
Phenazopyridine
Fluticasone
The metabolism of Selexipag can be decreased when combined with Fluticasone.
Phenazopyridine
Trametinib
The metabolism of Selexipag can be decreased when combined with Trametinib.
Phenazopyridine
Brofaromine
Brofaromine may increase the hypotensive activities of Selexipag.
Phenazopyridine
Harmaline
Harmaline may increase the hypotensive activities of Selexipag.
Phenazopyridine
Caroxazone
Caroxazone may increase the hypotensive activities of Selexipag.
Phenazopyridine
Safrazine
Safrazine may increase the hypotensive activities of Selexipag.
Phenazopyridine
Pivhydrazine
Pivhydrazine may increase the hypotensive activities of Selexipag.
Phenazopyridine
Phenoxypropazine
Phenoxypropazine may increase the hypotensive activities of Selexipag.
Phenazopyridine
Pheniprazine
Pheniprazine may increase the hypotensive activities of Selexipag.
Phenazopyridine
Octamoxin
Octamoxin may increase the hypotensive activities of Selexipag.
Phenazopyridine
Mebanazine
Mebanazine may increase the hypotensive activities of Selexipag.
Phenazopyridine
Benmoxin
Benmoxin may increase the hypotensive activities of Selexipag.
Phenazopyridine
Toloxatone
Toloxatone may increase the hypotensive activities of Selexipag.
Phenazopyridine
Pirlindole
Pirlindole may increase the hypotensive activities of Selexipag.
Phenazopyridine
Hydracarbazine
Hydracarbazine may increase the hypotensive activities of Selexipag.
Phenazopyridine
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypotensive activities of Selexipag.